(Q47674964)

4 February 2018

title

Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies (English)

1 reference

4 February 2018

0 references

1 reference

5

Massimo Loda

1 reference

4 February 2018

4

Kornelia Polyak

1 reference

4 February 2018

author name string

Eric L Snyder

series ordinal

1

1 reference

4 February 2018

Dyane Bailey

series ordinal

2

1 reference

4 February 2018

Michail Shipitsin

series ordinal

3

1 reference

4 February 2018

publication date

1 June 2009

1 reference

4 February 2018

published in

Laboratory Investigation

1 reference

4 February 2018

volume

89

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

page(s)

857-866

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2009.54

exact match

0 references

cites work

Recent advances in cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

The cancer stem cell hypothesis: in search of definitions, markers, and relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Molecular definition of breast tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Quantum dots as cellular probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Semiautomated multiplexed quantum dot-based in situ hybridization and spectral deconvolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

ID genes mediate tumor reinitiation during breast cancer lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

IL-6 regulates CD44 cell surface expression on human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.54

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2009.54

1 reference

4 February 2018

1 reference

4 February 2018